[Pantoprazole-induced hepatitis]

Dtsch Med Wochenschr. 2003 Mar 21;128(12):611-4. doi: 10.1055/s-2003-38050.
[Article in German]

Abstract

History: A 46-year-old woman presented for an emergency admission because of colic-like upper abdominal pain and markedly impaired general condition. Eight days before admission she had started and continued to take pantoprazole because of symptoms of gastroesophageal reflux.

Investigations: Clinical examination and laboratory tests indicated abnormal liver functions suggesting hepatitis. Serology largely excluded an infectious, autoimmunological or metabolic cause. Duplex sonography gave no evidence of bile obstruction or Budd-Chiari syndrome.

Diagnosis and course: The patient's condition and laboratory tests after the drug had been discontinued gradually improved on symptomatic treatment, indicating pantoprazole-induced hepatitis.

Conclusion: Intake of proton pump inhibitors is a rare cause but should be considered in the differential diagnosis of hepatitis of uncertain etiology.

Publication types

  • Case Reports

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Abdomen / diagnostic imaging
  • Abdominal Pain / chemically induced
  • Anti-Ulcer Agents / adverse effects*
  • Anti-Ulcer Agents / therapeutic use
  • Benzimidazoles / adverse effects*
  • Benzimidazoles / therapeutic use
  • Chemical and Drug Induced Liver Injury / diagnosis
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / therapy
  • Diagnosis, Differential
  • Enzyme Inhibitors / adverse effects*
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Gastroesophageal Reflux / drug therapy
  • Humans
  • Liver / blood supply
  • Liver / diagnostic imaging
  • Liver / drug effects
  • Middle Aged
  • Omeprazole / analogs & derivatives
  • Pantoprazole
  • Proton Pump Inhibitors*
  • Sulfoxides / adverse effects*
  • Sulfoxides / therapeutic use
  • Ultrasonography, Doppler, Duplex

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Enzyme Inhibitors
  • Proton Pump Inhibitors
  • Sulfoxides
  • Pantoprazole
  • Omeprazole